How many courses of Daratumumab are generally used?

The duration of treatment with Daratumumab (Daratumumab) is usually based on the patient's specific situation and the recommendations of the doctor. Generally, it can be used as a monotherapy or in combination with other anticancer drugs, and treatment can last for several months or even longer.

1.Monotherapy: In certain circumstances, daratumumab can be used as a stand-alone treatment option, especially in patients who cannot tolerate or are not suitable for other treatment options. In this case, treatment courses typically last several months, but the exact length of treatment may vary depending on the patient's condition and response.

2.Combination therapy: Daratumumab is often combined with other anti-cancer drugs to improve the effectiveness of the treatment. This combination treatment may include kinase inhibitors, hormone therapy, immunomodulatory drugs, etc. The length of a course of treatment is usually based on the patient's specific condition and treatment plan and can extend over several months or longer.

3.Maintenance therapy: For some patients, especially those who achieve remission after initial treatment, daratumumab may be continued for maintenance therapy to prolong the remission period. Maintenance treatment can be given for several years to help prevent recurrence of the disease.

4.Relapsed or refractory disease: For relapsed or refractory disease in multiple myeloma, daratumumab can still be used as a treatment option. In this case, treatment may be continued until the disease progresses further or the patient becomes unable to tolerate the treatment.

Daratumumab has been launched in China and has been included in medical insurance. Patients can purchase it domestically. The price is about more than 5,000. Medical insurance reimbursement must meet the reimbursement conditions. For specific prices and medical insurance policies, please consult the local hospital pharmacy or medical insurance bureau. Currently, there is only the original drug of daratumumab in foreign countries. The cheaper one is the Turkish original drug, which costs around 5,000. The ingredients and efficacy are consistent with the domestic original drug.